Nervgen Pharma Corp Stock Today

NGENF Stock  USD 1.59  0.07  4.61%   

Performance

0 of 100

 
Low
 
High
Very Weak

Odds Of Distress

Over 63

 
100  
 
Zero
Quite High
NervGen Pharma is trading at 1.59 as of the 28th of March 2024. This is a 4.61% increase since the beginning of the trading day. The stock's lowest day price was 1.52. NervGen Pharma has more than 63 % chance of experiencing financial distress in the next few years of operation. It also generated negative returns for investors over the last 90 days. Equity ratings for NervGen Pharma Corp are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 27th of February 2024 and ending today, the 28th of March 2024. Click here to learn more.
NervGen Pharma Corp., together with its subsidiaries, engages in the discovery, development, and commercialization of pharmaceutical treatments for medical conditions related to nervous system damage. NervGen Pharma Corp. was incorporated in 2017 and is based in Vancouver, Canada. The company has 58.68 M outstanding shares. More on NervGen Pharma Corp

Moving against NervGen OTC Stock

  0.59PRSEF ProsafePairCorr
  0.52MRNA Moderna Financial Report 2nd of May 2024 PairCorr
  0.48WXIBF WuXi BiologicsPairCorr

NervGen OTC Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. NervGen Pharma's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding NervGen Pharma or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Business ConcentrationBiotechnology, Healthcare (View all Sectors)
NervGen Pharma Corp [NGENF] is traded as part of a regulated electronic over-the-counter service offered by the NASD. The company currently falls under 'Micro-Cap' category with a current market capitalization of 87.43 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate NervGen Pharma's market, we take the total number of its shares issued and multiply it by NervGen Pharma's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. NervGen Pharma Corp classifies itself under Healthcare sector and is part of Biotechnology industry. The entity has 58.68 M outstanding shares. NervGen Pharma Corp has accumulated about 11.65 M in cash with (8.27 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.2.
Check NervGen Pharma Probability Of Bankruptcy
Ownership Allocation
NervGen Pharma Corp maintains a total of 58.68 Million outstanding shares. NervGen Pharma Corp holds significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check NervGen Ownership Details

NervGen Stock Price Odds Analysis

In reference to a normal probability distribution, the odds of NervGen Pharma jumping above the current price in 90 days from now is more than 94.0%. The NervGen Pharma Corp probability density function shows the probability of NervGen Pharma otc stock to fall within a particular range of prices over 90 days. Assuming the 90 days horizon NervGen Pharma has a beta of 0.3069. This indicates as returns on the market go up, NervGen Pharma average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding NervGen Pharma Corp will be expected to be much smaller as well. Additionally, nervGen Pharma Corp has an alpha of 0.357, implying that it can generate a 0.36 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
  Odds Below 1.59HorizonTargetOdds Above 1.59
6.47%90 days
 1.59 
93.50%
Based on a normal probability distribution, the odds of NervGen Pharma to move above the current price in 90 days from now is more than 94.0 (This NervGen Pharma Corp probability density function shows the probability of NervGen OTC Stock to fall within a particular range of prices over 90 days) .

NervGen Pharma Corp Risk Profiles

Investors will always prefer to have the highest possible return on investment while minimizing volatility. NervGen Pharma market risk premium is the additional return an investor will receive from holding NervGen Pharma long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in NervGen Pharma. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although NervGen Pharma's alpha and beta are two of the key measurements used to evaluate NervGen Pharma's performance over the market, the standard measures of volatility play an important role as well.

NervGen Stock Against Markets

Picking the right benchmark for NervGen Pharma otc stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in NervGen Pharma otc stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for NervGen Pharma is critical whether you are bullish or bearish towards NervGen Pharma Corp at a given time. Please also check how NervGen Pharma's historical prices are related to one of the top price index indicators.

Be your own money manager

Our tools can tell you how much better you can do entering a position in NervGen Pharma without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Aroon Oscillator Now

   

Aroon Oscillator

Analyze current equity momentum using Aroon Oscillator and other momentum ratios
All  Next Launch Module

NervGen Pharma Corporate Management

Elected by the shareholders, the NervGen Pharma's board of directors comprises two types of representatives: NervGen Pharma inside directors who are chosen from within the company, and outside directors, selected externally and held independent of NervGen. The board's role is to monitor NervGen Pharma's management team and ensure that shareholders' interests are well served. NervGen Pharma's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, NervGen Pharma's outside directors are responsible for providing unbiased perspectives on the board's policies.
Brian McAlisterCoFounder AdvisorProfile
Harold DMDCoFounder DirectorProfile
Adam MDInterim DirectorProfile
William BAScInterim CoFounderProfile

How to buy NervGen OTC Stock?

Before investing in NervGen Pharma, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in NervGen Pharma. To buy NervGen Pharma stock, you can follow these steps:
  • Choose a brokerage firm: You need to select a brokerage firm to buy shares of NervGen Pharma. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
  • Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
  • Fund your account: You will need to deposit funds into your brokerage account to purchase NervGen Pharma stock. You can do this by transferring funds from your bank account or other investment accounts.
  • Place your order: Once you have located NervGen Pharma Corp stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
  • Monitor your investment: After you have purchased NervGen Pharma Corp stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as NervGen Pharma Corp, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments.

Already Invested in NervGen Pharma Corp?

The danger of trading NervGen Pharma Corp is mainly related to its market volatility and OTC Stock specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of NervGen Pharma is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than NervGen Pharma. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile NervGen Pharma Corp is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in NervGen Pharma Corp. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.
You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.

Complementary Tools for NervGen OTC Stock analysis

When running NervGen Pharma's price analysis, check to measure NervGen Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NervGen Pharma is operating at the current time. Most of NervGen Pharma's value examination focuses on studying past and present price action to predict the probability of NervGen Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NervGen Pharma's price. Additionally, you may evaluate how the addition of NervGen Pharma to your portfolios can decrease your overall portfolio volatility.
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
CEOs Directory
Screen CEOs from public companies around the world
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Please note, there is a significant difference between NervGen Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if NervGen Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, NervGen Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.